Stocks With The Most
Fund Call Options
| Name | Net Calls | Calls | Puts |
Return since 31 Dec ‘13 |
|
|---|---|---|---|---|---|
| $43.6M | $115M | $71.9M | 46.1% |
|
|
| $42.7M | $49.6M | $6.89M | 443% |
|
|
| $42.6M | $126M | $83.4M | 13.6% |
|
|
29
RH
RH
$2.93B
| $42.1M | $62.8M | $20.7M | 132% |
|
| $41.8M | $93.7M | $51.9M | 356% |
|
|
| $40.6M | $78.8M | $38.2M | 94% |
|
|
| $39.6M | $44.7M | $5.15M | 15% |
|
|
| $39M | $68.9M | $29.9M | 8.15% |
|
|
| $36.4M | $98M | $61.5M | 76.3% |
|
|
| $35.6M | $39.1M | $3.46M | 71.9% |
|
|
36
State Street SPDR S&P Biotech ETF
XBI
$8.19B
| $34.8M | $41.9M | $7.04M | 188% |
|
| $34.8M | $49M | $14.2M | 190% |
|
|
| $33.4M | $57M | $23.6M | 25.4% |
|
|
| $33.2M | $159M | $125M | 138% |
|
|
| $32.6M | $129M | $96M | 27% |
|
|
| $31.9M | $47.1M | $15.2M | 10.7% |
|
|
| $29.5M | $47.8M | $18.3M | 342% |
|
|
| $28.7M | $36.2M | $7.45M | 201% |
|
|
| $28.3M | $132M | $103M | 84.3% |
|
|
| $26.7M | $138M | $111M | 210% |
|
|
| $26.5M | $101M | $74.7M | 25.7% |
|
|
| $25.4M | $33.6M | $8.16M | 25.8% |
|
|
| $24.5M | $120M | $95.3M | 7.68% |
|
|
| $23.8M | $214M | $190M | 66.9% |
|
|
| $22.1M | $104M | $82.3M | 319% |
|